Browsing byAuthorChellappan, DK

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 242 to 261 of 370< previous   next >
Issue DateTitleAuthor(s)
2020-01-18Obesity and Diabetes: Pathophysiology of Obesity-Induced Hyperglycemia and Insulin ResistanceGupta, G; Wadhwa, R; Pandey, P; Singh, SK; Gulati, M; Satija, S; Mehta, M; Singh, AK; Dureja, H; Collet, T; Pabreja, K; Chellappan, DK; Dua, K
2019-08-01Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseasesMehta, M; Deeksha; Tewari, D; Gupta, G; Awasthi, R; Singh, H; Pandey, P; Chellappan, DK; Wadhwa, R; Collet, T; Hansbro, PM; Kumar, SR; Thangavelu, L; Negi, P; Dua, K; Satija, S
2022-10Oligonucleotides: A novel area of interest for drug delivery in neurodegenerative diseasesAlharbi, KS; Javed Shaikh, MA; Afzal, O; Alfawaz Altamimi, AS; Hassan almalki, W; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Babu, MR; Singh, SK; Chellappan, DK; Dua, K; Gupta, G
2022-01-01One-step synthesis of picolinohydrazides from fusaric acid: DFT, structural characterization and molecular inhibitory studies on metastatic tumor-derived exosomal and non-exosomal proteinsAnand, K; Ramesh, M; Singh, T; Balakumar, C; Chithravel, V; Prasher, P; Katari, NK; Gupta, G; Singh, SK; Chellappan, DK; Dua, K; Chavda, V; Laishevtcev, A; Shahbaaz, M; Abdellattif, MH; Saravanan, M; Chuturgoon, AA
2020-12-27Opening eyes to therapeutic perspectives of bioactive polyphenols and their nanoformulations against diabetic neuropathy and related complications.Khursheed, R; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Awasthi, A; Kr, A; Kumar, R; Pottoo, FH; Kumar, V; Dureja, H; Anand, K; Chellappan, DK; Dua, K; Gowthamarajan, K
2022-01-01Optimization Studies on Imatinib Mesylate Loaded Nanoliposomes Using Box-Behnken DesignDahiya, M; Awasthi, R; Gupta, G; Singh, SK; Gulati, M; Jha, NK; Jha, SK; Sharma, A; Prasher, P; Anand, K; Chellappan, DK; Dua, K; Dureja, H
2022-09-01Orally administered solasodine, a steroidal glycoalkaloid, suppresses ovalbumin-induced exaggerated Th2-immune response in rat model of bronchial asthmaArora, P; Nainwal, LM; Gupta, G; Singh, SK; Chellappan, DK; Oliver, BG; Dua, K
2022-01-12Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective.Hemrajani, C; Negi, P; Parashar, A; Gupta, G; Jha, NK; Singh, SK; Chellappan, DK; Dua, K
2021-12-16Overcoming hydrolytic degradation challenges in topical delivery: Non-aqueous nano-emulsions.Kadukkattil Ramanunny, A; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Khursheed, R; Kuppusamy, G; Dua, K; Dureja, H; Chellappan, DK; Jha, NK; Gupta, PK; Vishwas, S
2020-12-01Overcoming the dissolution rate, gastrointestinal permeability and oral bioavailability of glimepiride and simvastatin co-delivered in the form of nanosuspension and solid self-nanoemulsifying drug delivery system: A comparative studyPandey, NK; Singh, SK; Gulati, M; Kumar, B; Kapoor, B; Ghosh, D; Kumar, R; Khursheed, R; Awasthi, A; Kuppusamy, G; Wadhwa, S; Satija, S; Dureja, H; Jain, SK; Chellappan, DK; Anand, K; Mehta, M; Dua, K
2018-01-01An overview of circular RNAsAwasthi, R; Singh, AK; Mishra, G; Maurya, A; Chellappan, DK; Gupta, G; Hansbro, PM; Dua, K
2021-08Overview of key molecular and pharmacological targets for diabetes and associated diseasesShahcheraghi, SH; Aljabali, AAA; Al Zoubi, MS; Mishra, V; Charbe, NB; Haggag, YA; Shrivastava, G; Almutary, AG; Alnuqaydan, AM; Barh, D; Dua, K; Chellappan, DK; Gupta, G; Lotfi, M; Serrano-Aroca, Á; Bahar, B; Mishra, YK; Takayama, K; Panda, PK; Bakshi, HA; Tambuwala, MM
2020-06-16Oxidative Stress and Immunological Complexities in Multidrug-Resistant TuberculosisWadhwa, R; Sehgal, N; G, N; Aggarwal, T; Satija, S; Mehta, M; Gupta, G; Chellappan, DK; Tambuwala, MM; Oliver, B; Collet, T; Maurya, PK; Hansbro, PM; Dua, K
2020-06-16Oxidative Stress in Liver DiseaseSingh, L; Majhi, S; Pabreja, K; Negi, P; Goyal, R; Gupta, G; Chellappan, DK; Dua, K
2020-01-01Oxidative stress in neurology and in neurodegenerative processesGupta, G; Pathak, S; Rawat, S; Mishra, A; Singh, Y; Mehta, M; Satija, S; Khurana, N; De Jesus Andreoli Pinto, T; Shukla, S; Pabreja, K; Chellappan, DK
2020-05Patented therapeutic drug delivery strategies for targeting pulmonary diseases.Thakur, AK; Chellappan, DK; Dua, K; Mehta, M; Satija, S; Singh, I
2021Perfluorocarbons Therapeutics in Modern Cancer Nanotechnology for Hypoxiainduced Anti-tumor Therapy.Satija, S; Sharma, P; Kaur, H; Dhanjal, DS; Chopra, RS; Khurana, N; Vyas, M; Sharma, N; Tambuwala, MM; Bakshi, HA; Charbe, NB; Zacconi, FC; Chellappan, DK; Dua, K; Mehta, M
2018-09-01Peroxisome proliferator-activated receptor gamma: Promising target in glioblastomaGupta, G; Singhvi, G; Chellappan, DK; Sharma, S; Mishra, A; Dahiya, R; De Jesus Andreoli Pinto, T; Dua, K
2020-08-06Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.Tan, YY; Yap, PK; Xin Lim, GL; Mehta, M; Chan, Y; Ng, SW; Kapoor, DN; Negi, P; Anand, K; Singh, SK; Jha, NK; Lim, LC; Madheswaran, T; Satija, S; Gupta, G; Dua, K; Chellappan, DK
2021-01-01Pharmaceutical aspects of green synthesized silver nanoparticles: A boon to cancer treatment.Mishra, V; Nayak, P; Singh, M; Tambuwala, MM; Aljabali, AA; Chellappan, DK; Dua, K